Plain-English translation of NCT07040618 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different ultrasound-guided nerve-blocking injections—called a Rhomboid Intercostal Block and an Erector Spinae Plane Block—to help manage pain after lung cancer surgery. Both injections use a local anesthetic (bupivacaine) and are given just before surgery. The study will compare which injection helps patients need less morphine pain medication after their operation and keeps them more comfortable during recovery.
Lung cancer surgery (thoracotomy) causes severe pain that, if not controlled well, can lead to long-term pain problems and make it harder for patients to breathe properly after surgery. These two newer nerve-blocking techniques may offer better pain relief with fewer side effects than older methods, and researchers want to find out which one works better.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive one of the two nerve-blocking injections about 30–45 minutes before your scheduled lung cancer surgery. The injection will be guided by ultrasound imaging to ensure it's placed correctly. After surgery, researchers will monitor your pain levels, how much pain medication you need, how stable your vital signs are, and how satisfied you are with your pain control over the next 24 hours and during your recovery.
AI-generated summary from trial data · Sep 20, 2026 · Not medical advice
Egypt